Keyphrases
Intraocular Pressure
100%
Rodents
100%
Nanoencapsulation
100%
Hybrid Compounds
100%
Trabecular Meshwork Cells
88%
2-NP
55%
Eye Drops
44%
Glaucoma
33%
Hypertensive
33%
Cyclic GMP
33%
NP-1
33%
Outflow Facility
22%
EC50
22%
Superoxide Dismutase 1 (SOD1)
22%
Rat Eye
22%
Tert-butyl Hydroperoxide (t-BHP)
22%
Episcleral Venous Pressure
22%
Nanosuspension
22%
Cell Survival
11%
Antioxidant
11%
Commercial Kits
11%
Glaucomatous
11%
Reactive Oxygen Species
11%
Mouse Eye
11%
Aqueous Humor Outflow
11%
Vision Loss
11%
Neurodegenerative Diseases
11%
Retina
11%
Poly(D,L-lactic-co-glycolic acid)
11%
Aqueous Humor
11%
Prostaglandins
11%
Eye Diseases
11%
Dosing Regimen
11%
Morrisons
11%
Hypertensive Rats
11%
Triplicate
11%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
11%
Effective Concentration
11%
Superoxide Dismutase
11%
Enzyme Activity
11%
Rodent Models
11%
Aqueous Outflow Facility
11%
Cell Proliferation Assay
11%
3-group
11%
Cornea
11%
PLGA Nanoparticles
11%
Biodistribution Studies
11%
Slow Release
11%
Sclera
11%
Multiple Flows
11%
Manometry
11%
Activity Study
11%
Nitric Oxide Scavenging
11%
Escalating Dose
11%
Nonencapsulated
11%
Prevalence Estimation
11%
Nitric Oxide-donating
11%
Single Eye
11%
Vitreous Humor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Glaucoma
100%
Cytoprotective Agent
100%
Cyclic GMP
100%
Superoxide Dismutase
100%
EC50
100%
Hydrogen Peroxide
66%
Nitric Oxide
33%
Reactive Oxygen Metabolite
33%
Visual Impairment
33%
Degenerative Disease
33%
Glycolic Acid
33%
Nanoparticle
33%
High Performance Liquid Chromatography
33%
Prevalence
33%
Antioxidant
33%
Superoxide
33%
Prostaglandin
33%
Biodistribution
33%